{"id":163821,"date":"2023-05-13T18:23:25","date_gmt":"2023-05-13T23:23:25","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/05\/new-alzheimers-drug-shows-35-reduction-in-cognitive-decline-in-late-stage-trial"},"modified":"2023-05-13T18:23:25","modified_gmt":"2023-05-13T23:23:25","slug":"new-alzheimers-drug-shows-35-reduction-in-cognitive-decline-in-late-stage-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/05\/new-alzheimers-drug-shows-35-reduction-in-cognitive-decline-in-late-stage-trial","title":{"rendered":"New Alzheimer\u2019s Drug Shows 35% Reduction in Cognitive Decline in Late-Stage Trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/new-alzheimers-drug-shows-35-reduction-in-cognitive-decline-in-late-stage-trial2.jpg\"><\/a><\/p>\n<p>American pharmaceutical company Eli Lilly announced last week that it had seen <a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-donanemab-significantly-slowed-cognitive-and-functional\">encouraging clinical trial results<\/a> of its new <a href=\"https:\/\/www.sciencealert.com\/go\/IaO\" class=\"\" rel=\"nofollow\" target=\"_self\">Alzheimer\u2019s<\/a> medication.<\/p>\n<p>According to the company, their experimental drug, donanemab, was shown in a late-stage trial to slow cognitive decline by 35 percent.<\/p>\n<p>While these results do sound promising, the full data is not yet released, so there\u2019s still a lot we don\u2019t know.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>American pharmaceutical company Eli Lilly announced last week that it had seen encouraging clinical trial results of its new Alzheimer\u2019s medication. According to the company, their experimental drug, donanemab, was shown in a late-stage trial to slow cognitive decline by 35 percent. While these results do sound promising, the full data is not yet released, [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-163821","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/163821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=163821"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/163821\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=163821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=163821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=163821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}